Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPS5951535B2 - 2-amino-5-methylpyridine-3-sulfonamide and anticoccidial agent containing it as an active ingredient - Google Patents
[go: Go Back, main page]

JPS5951535B2 - 2-amino-5-methylpyridine-3-sulfonamide and anticoccidial agent containing it as an active ingredient - Google Patents

2-amino-5-methylpyridine-3-sulfonamide and anticoccidial agent containing it as an active ingredient

Info

Publication number
JPS5951535B2
JPS5951535B2 JP9552376A JP9552376A JPS5951535B2 JP S5951535 B2 JPS5951535 B2 JP S5951535B2 JP 9552376 A JP9552376 A JP 9552376A JP 9552376 A JP9552376 A JP 9552376A JP S5951535 B2 JPS5951535 B2 JP S5951535B2
Authority
JP
Japan
Prior art keywords
methylpyridine
amino
sulfonamide
test
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP9552376A
Other languages
Japanese (ja)
Other versions
JPS5321171A (en
Inventor
靖弘 森沢
満 片岡
訓敏 北野
健一 草野
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Priority to JP9552376A priority Critical patent/JPS5951535B2/en
Publication of JPS5321171A publication Critical patent/JPS5321171A/en
Publication of JPS5951535B2 publication Critical patent/JPS5951535B2/en
Expired legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)

Description

【発明の詳細な説明】 本発明は2−アミノー 5−メチルピリジンー3−スル
ホンアミド、およびそれを有効成分とする抗コクシジウ
ム剤に関するものである。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to 2-amino-5-methylpyridine-3-sulfonamide and an anticoccidial agent containing the same as an active ingredient.

2−アミノー 5−メチルピリジンー 3−スルホンア
ミドは新規物質であり、次の方法により合成することが
できる。
2-Amino-5-methylpyridine-3-sulfonamide is a new substance and can be synthesized by the following method.

2−アミノー 5−メチルピリジンをクロルスルホン酸
と加熱後、更にチオニルクロリドと反応させ、2−アミ
ノー 5−メチルピリジンー 3−スルホン酸クロリド
を合成、続いてアンモニアと接触させて得られる。
After heating 2-amino-5-methylpyridine with chlorosulfonic acid, it is further reacted with thionyl chloride to synthesize 2-amino-5-methylpyridine-3-sulfonic acid chloride, which is then brought into contact with ammonia.

次に実施例を示して、さらに詳細に説明する。Next, examples will be shown to explain in more detail.

実施例2−アミノー 5−メチルピリジンー 3−スル
ホンアミドの合成2−アミノー 5−メチルピリジン2
1.69をクロルスルホン酸1169に攪拌下に15℃
以下で加える。
Example 2 - Synthesis of amino-5-methylpyridine-3-sulfonamide 2-amino-5-methylpyridine 2
1.69 to chlorosulfonic acid 1169 at 15°C with stirring.
Add below.

この溶液は150℃で100時間加熱攪拌後、室温にも
どし、チオニルクロリド3Owjを滴下する。激しくガ
スが発生する。満下後、125℃で2時間加熱攪拌する
。氷水に反応混合物を加え、析出する結晶をクロロホル
ムで抽出する。抽出液は水洗、乾燥後アンモニヤガスを
通じ、析出する結晶を水より再結晶すると触点183−
185℃を示す所望の化合物309が得られた。元素分
析値C6H0N802Sとして 計算値:C、38.50:H、4.85■N222.4
5:5|17.10実験値:C238.45:H、4.
65■N322.68:5|16.96この化合物は抗
コクシジウム剤として有用であり、特に病原性の強い盲
腸寄生のアイメリア・テネラ(Eimeriatene
lla)に対して著効を示す。
This solution was heated and stirred at 150° C. for 100 hours, then returned to room temperature, and 3Owj of thionyl chloride was added dropwise. Gas is generated violently. After the temperature has dropped to 125°C, the mixture is heated and stirred at 125°C for 2 hours. Add the reaction mixture to ice water, and extract the precipitated crystals with chloroform. The extract is washed with water, dried, passed through ammonia gas, and the precipitated crystals are recrystallized from water to give a contact point of 183-
The desired compound 309 was obtained exhibiting a temperature of 185°C. Calculated value as elemental analysis value C6H0N802S: C, 38.50:H, 4.85■N222.4
5:5 | 17.10 Experimental value: C238.45:H, 4.
65 ■ N322.68:5 | 16.96 This compound is useful as an anti-coccidial agent, and is particularly effective against Eimeria tenella, a highly pathogenic caecal parasite.
lla).

さらに本化合物は現在広く用いられているチアミ。ン系
コクシジウム剤の耐性株にも著効を示す。本発明の化合
物を抗コクシジウム剤として使用するには2−アミノー
5−メチルピリジンー3ースルホンアミドを必要に応
じて生理的に無害な担体と配合して用いられる。通常は
動物用飼料に配合、または飲料水に溶解して用いられる
。動物用飼料としては例えば穀粉、外皮、醗酵残留物、
粕類、糖類があげられる。この試料には粉砕した石灰石
、タルク末などを混合してもよく、混合は粉砕、撹拌、
転磨のような方法によつて固体または半固体に製造する
。本発明の上記調製物には他の抗コクシジウム剤例えば
サルフアクロルピラジン、スルフアジメトキシン、スル
フアキノキサリンのようなサルフア剤:あるいはチアミ
ン誘導体例えばベクロチアミン、アンプロリウム、ジメ
チアリウムリキノリン誘導体例えばプキノレート、デコ
キネート、メチルベンゾクウエート:葉酸拮抗物質例え
ばピリメタミン、ジアベリジン:抗生物質例えばモネン
シン:あるいはその他の抗コクシジウム剤例えば3−ヒ
ドロキシ− 5 −ヒドロキシメチル− 2 −メチル
ピリジン、クロピドール(3,5−ジクロル−2.6−
ジメチル− 4 −ピリジノール)、ロベンジデンなど
を含有せしめてもよい。
Furthermore, this compound is thiami, which is currently widely used. It is also highly effective against strains resistant to coccidial agents. In order to use the compound of the present invention as an anticoccidial agent, 2-amino-5-methylpyridine-3-sulfonamide is used, if necessary, in combination with a physiologically harmless carrier. It is usually added to animal feed or dissolved in drinking water. Animal feeds include, for example, flour, hulls, fermentation residues,
Examples include lees and sugars. This sample may be mixed with crushed limestone, talc powder, etc., and mixing can be done by crushing, stirring,
Manufactured into solid or semi-solid forms by methods such as rolling. The above preparations of the invention may contain other anticoccidial agents such as sulfur agents such as sulfachlorpyrazine, sulfadimethoxine, sulfaquinoxaline; or thiamine derivatives such as vecrothiamine, amprolium, dimethylium liquinoline derivatives such as puquinolate, decoquinate, Methylbenzokuwait: Folate antagonists e.g. pyrimethamine, diaveridine: Antibiotics e.g. monensin: or other anticoccidial agents e.g. 3-hydroxy-5-hydroxymethyl-2-methylpyridine, clopidol (3,5-dichlor-2,6-
Dimethyl-4-pyridinol), lobenzidene, etc. may be contained.

本発明の化合物の投与濃度は家禽および家畜の種類、投
与方法、投与目的、症状等によつて一概にはいえないが
、例えば飼料添加して予防する場合は25〜 250p
pmで用いられ、治療には500〜1000ppmで使
用される。
The dosage concentration of the compound of the present invention cannot be determined unconditionally depending on the type of poultry or livestock, administration method, purpose of administration, symptoms, etc., but for example, when preventing by adding it to feed, it is 25 to 250p.
pm and for treatment at 500-1000 ppm.

次に本発明の化合物の抗コクシジウム剤としての効果を
示す試験例をあげる。
Next, a test example showing the effect of the compound of the present invention as an anticoccidial agent will be given.

試験例 供試材料および試験方法 1)供試ヒナ:単冠白色レグホン種、雄ヒナ、実験開始
14日令(ふ化後直ちに初生ヒナを試験開始まで抗コク
シジウム剤を含有しない幼雛用配合飼料を給与して隔離
飼育した。
Test Example Test Materials and Test Methods 1) Test chicks: single crowned white leghorn, male chicks, 14 days old from the start of the experiment (immediately after hatching, day-old chicks were fed a compound feed for young chicks that did not contain an anticoccidial agent until the start of the test) They were fed and kept in isolation.

)2)供試コクシジウムリアイメリア・テネラ(ElI
Teriatenella)の胞子形成オーシストを1
羽当り42000個ずつ直接そのう内に経口接種して感
染させた。
)2) Test coccidium Eimeria tenella (ElI
1 sporulating oocyst of Teriatenella)
Infection was carried out by orally inoculating 42,000 eggs per wing directly into the pouch.

3)供試薬剤:2−アミノ− 5 −メチルピリジン−
3 −スルホンアミド4)供試薬剤の飼料への添加濃
度:抗コクシジウム剤を含有しない市販の幼雛用配合飼
料に供試薬剤を200ppm混合した。
3) Test drug: 2-amino-5-methylpyridine-
3-Sulfonamide 4) Concentration of test drug added to feed: 200 ppm of the test drug was mixed into a commercially available compounded feed for young chicks that did not contain an anti-coccidial agent.

5)試験方法:上記供試ヒナをコクシジウム症鶏から隔
離飼育し、健康状態を観察し、正常なヒナについて体重
を測定し、各区の平均体重に有意差(危険率5%水準フ
のないように10羽/区ずつに区分した。
5) Test method: The above test chicks were raised in isolation from chickens with coccidiosis, their health conditions were observed, and the weight of normal chicks was measured. The birds were divided into 10 birds per area.

さらに感染無投薬対照および無投薬無感染対照の2群を
設けた。区分け後、無感染無投薬対照区を除く全区にオ
ーシストの一定数を接種し、同時に供試薬剤を含有する
飼料を給与し、対照の2つの区には供試薬剤を添加しな
い同一組成(同一ロツト)の飼料を給与した。6)判定
:試験開始時(投薬および感染時)から終了時(感染後
7F3)まで一定時刻に体重を測定し、感染後6〜7日
までに排泄された舞中のオーシスト数を毎日測定した。
Furthermore, two groups were established: an infection-free control and a no-medication and infection-free control. After dividing, a certain number of oocysts were inoculated in all plots except for the uninfected and unmedicated control plot, and feed containing the test drug was fed at the same time, and the two control plots were fed with feed containing the same composition (without the test drug). Feed from the same lot was fed. 6) Judgment: Body weight was measured at certain times from the start of the test (during administration and infection) to the end (7F3 after infection), and the number of oocysts excreted during the 6-7 days after infection was measured every day. .

感染後7日目に全生存ヒナを剖検し、コクシジウムによ
る盲腸の病変の程度をエキスペリメンタル・パラシトロ
ジ一 (Exptl−Parasit)第28巻30〜
36ページ(1970年)記載のジヨンソン・アンド・
リード(JOhnsOnandROld)の方法によV
)0 〜 4の5段法により判定した。試験開始時から
終了時までの体重増加量を増体量とし、各試験区の羽数
で除したものを平均増体量とした。
All surviving chicks were necropsied on the 7th day after infection, and the degree of cecal lesions caused by coccidia was determined using Experimental Parasitology Vol. 28, 30-
Johnson &
By the method of JOhnsOnandROld
) Judgment was made using a 5-stage method of 0 to 4. The amount of weight gain from the start of the test to the end of the test was defined as the amount of weight gain, and the value divided by the number of birds in each test section was defined as the average amount of weight gain.

感染後6日および7日に排池された糞11中のオーシス
ト数を各試験区ごとに加算してオーシスト数とした。
The number of oocysts in the feces 11 discharged on the 6th and 7th days after infection was added for each test area to obtain the oocyst count.

試験結果 表1に示す。Test results It is shown in Table 1.

Claims (1)

【特許請求の範囲】 1 2−アミノ−5−メチルピリジン−3−スルホンア
ミド。 2 2−アミノ−5−メチルピリジン−3−スルホンア
ミドを有効成分とする抗コクシジウム剤。
[Claims] 1 2-Amino-5-methylpyridine-3-sulfonamide. 2. An anticoccidial agent containing 2-amino-5-methylpyridine-3-sulfonamide as an active ingredient.
JP9552376A 1976-08-11 1976-08-11 2-amino-5-methylpyridine-3-sulfonamide and anticoccidial agent containing it as an active ingredient Expired JPS5951535B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP9552376A JPS5951535B2 (en) 1976-08-11 1976-08-11 2-amino-5-methylpyridine-3-sulfonamide and anticoccidial agent containing it as an active ingredient

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9552376A JPS5951535B2 (en) 1976-08-11 1976-08-11 2-amino-5-methylpyridine-3-sulfonamide and anticoccidial agent containing it as an active ingredient

Publications (2)

Publication Number Publication Date
JPS5321171A JPS5321171A (en) 1978-02-27
JPS5951535B2 true JPS5951535B2 (en) 1984-12-14

Family

ID=14139912

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9552376A Expired JPS5951535B2 (en) 1976-08-11 1976-08-11 2-amino-5-methylpyridine-3-sulfonamide and anticoccidial agent containing it as an active ingredient

Country Status (1)

Country Link
JP (1) JPS5951535B2 (en)

Also Published As

Publication number Publication date
JPS5321171A (en) 1978-02-27

Similar Documents

Publication Publication Date Title
UA75085C2 (en) Heteroaryl derivatives and use thereof as pharmaceutical preparations
IE52021B1 (en) Clonidine derivatives useful in the treatment of diarrhoea
JPS6018658B2 (en) Method for producing 1-(4-phenoxy-phenyl)-1,3,5-triazine derivative
JP2002532545A (en) Triazine-on compounds for the treatment of diseases caused by carcinospores, precocious sporeworms and toxoplasma
KR920002130B1 (en) Process for the preparation of 1-|4-(benzothia-or-oxazol-2-yl thio-or-2-yl oxy) phenyl¨-1,3,5-triazine-2,4,6-(1h,3h,5h)-trione
JPS5874607A (en) Anticoccidial composition
US20240148744A1 (en) Sulfonamides and their use for treatment of helminthic infections and diseases
US3970752A (en) Coccidiocidal compositions utilizing 1-phenyl-substituted 1,3,5-triazine
HU183749B (en) Process for preparing new guanidine derivatives
KR20010080571A (en) Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma
JPS5951535B2 (en) 2-amino-5-methylpyridine-3-sulfonamide and anticoccidial agent containing it as an active ingredient
DE1933112C3 (en) Substituted 1,3-bis (benzylideneamino) guanidines
EP1082909A1 (en) Steroidal sapogenins for the control of coccidiosis in animals
US3781290A (en) Phenoxyphenyl phenylthiophenyl and phenylaminophenyl piperazinylthio-ureas
Snieszko et al. The effect of some sulfonamides on the growth of brook trout, brown trout, and rainbow trout
EP0086774A1 (en) Treatment of coccidial infections with amidinourea or amidinothiourea derivatives
US3518305A (en) Nitro-trifluoromethylbenzamides
Schildknecht et al. Antiparasitic activity of natural and semisynthetic monensin urethanes
US3555085A (en) Nitro-trifluoromethylthiobenzamides
US2877154A (en) Anthelmintic compositions containing chlorine substituted amides and methods for using same
US3928437A (en) Phenoxy-phenyl, phenylthiophenyl, phenylsulfonylphenyl and phenylaminophenyl diaminothioureas
US2831795A (en) Practice for the raising and protection of animals
JPS5813525B2 (en) anticoccidial agent
JPS5951524B2 (en) anticoccidial agent
US3632777A (en) Nitro - trifluoromethylbenzamides and veterinary compositions containing the same